comparemela.com

Latest Breaking News On - Factor xa inhibitors - Page 1 : comparemela.com

Andexanet Aids Hemostasis in ICH Tied to FXa Inhibitors

While the new drug reduced hematoma expansion compared with usual care, it was also associated with an increase in thrombotic events in the ANNEXa-I study.

City ofUnited kingdomAshkan shoamaneshRustam al shahi salmanStuart connollyAndexxa ondexxyaMcmaster universityNational institutes of health stroke scaleWorld stroke congressUniversity of edinburghNational institutesHealth stroke scaleRankin scaleMedscape cardiologyAl shahi salmanErebrovascular accident

FREEDOM COVID: Full-Dose Anticoagulation Cut Mortality

In an in-hospital anticoagulation trial, the primary COVID endpoint was missed, but a survival benefit was observed.

New yorkUnited statesHong kongCity ofUnited kingdomValentin fusterJulia grapsaWorld heart federationAcademic research consortiumMount sinai school of medicineJournal of the american college cardiologyAmerican college of cardiologyAmerican collegeWorld heartMount sinai hospitalLatin america

Factor Xa Inhibitors Tied to Interstitial Lung Disease in AF

Use of factor Xa inhibitors was associated with a higher risk of interstitial lung disease in Taiwanese patients with nonvalvular atrial fibrillation.

United statesMemorial hospitalNorth carolinaDuke university medical centerLinkou chang gungJonathan paul picciniEmanuel raschiDuke heart centerTaiwan national health insurance research databaseBoston scientificUniversity of bolognaGregory lipLinkou chang gung memorial hospitalTaoyuan cityPaul picciniNorth america

A Week of Anticoagulation Halves Post-PCI Radial Occlusion Rate

Seven days of a factor Xa inhibitor following a radial-access intervention reduces radial occlusion risk.

New yorkUnited statesRania hammamiRoxanna mehranIcahn school of medicine at mount sinaiAcademic research consortiumCardiovascular research foundationTranscatheter cardiovascular therapeuticsHedi chaker hospitalCardiovascular researchBleeding academic research consortiumIcahn schoolMount sinaiFactor xa inhibitorsAcute coronary syndrome acsCute coronary syndrome

Two Old Meds and a DOAC a Bust in COVID-19: The ACT Trials

It s the end of the story for colchicine in COVID-19, an expert said. In addition, aspirin does not help outpatients with COVID and a low-dose oral anticoagulant does not improve inpatient outcomes.

United statesComunidad autonoma de catalunaDavid bergJohn eikelboomSanjit jollyEuropean society of cardiology congressMcmaster universityMaastricht universityPopulation health research instituteAnti coronavirus therapyEuropean societyCardiology congressArteriovenous thrombotic eventsCritically ill019 novel coronavirus019 ncov

vimarsana © 2020. All Rights Reserved.